Techne Corp (NASDAQ:TECH)

95.52
Data as of Aug 29
 +0.46 / +0.48%
Today’s Change
75.43
Today|||52-Week Range
97.15
+0.90%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.5B

Company Description

TECHNE Corp. is engaged in the development, manufacture and sale of biotechnology products and hematology calibrators and controls. Techne operates through two segments: Biotechnology and Hematology. The Biotechnology segment develops, manufactures and sells biotechnology research and diagnostic products, including proteins such as cytokines and related reagents, to the biotechnology research community. The Hematology segment develops and manufactures hematology controls and calibrators for sale world-wide. The company was founded on July 17, 1981 and is headquartered in Minneapolis, MN.

Contact Information

Techne Corp.
614 McKinley Place NE
Minneapolis Minnesota 55413-2610
P:(612) 379-8854
Investor Relations:

Employees

Shareholders

Mutual fund holders52.47%
Other institutional44.77%
Individual stakeholders4.90%

Top Executives

Charles R. KummethPresident & Chief Executive Officer
James T. HippelChief Financial Officer
J. Fernando BazanChief Technology Officer
Brenda S. FurlowSenior Vice President & General Counsel
Marcel VeronneauVice President-Clinical Controls

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.